HBV antigens quantity: duration and effect on functional cure
- PMID: 34799373
- DOI: 10.1136/gutjnl-2021-326258
HBV antigens quantity: duration and effect on functional cure
Keywords: hepatitis B.
Conflict of interest statement
Competing interests: AB declares the following relationship with commercial entities developing therapeutics for HBV treatment. He acted as a consultant and served on the advisory boards of Assembly Biosciences, Gilead Sciences, Roche, Jansseen-Cilag, Vir, Molecular Therapies and HUMABS BioMed. AB is also a co-founder of LION TCR Pte. a biotech company developing T-cell receptors for treatment of virus-related cancers and chronic viral diseases.
Comment on
-
Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection.Gut. 2022 Nov;71(11):2300-2312. doi: 10.1136/gutjnl-2021-324646. Epub 2021 Oct 26. Gut. 2022. PMID: 34702717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources